Dashboard
Manage Tickers

MRNA Moderna, Inc.

Nasdaq modernatx.com


$ 24.31 $ 0.00 (0 %)    

Friday, 07-Nov-2025 04:37:50 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 611.97 $ 0.00 (0 %)
DIA $ 469.50 $ 0.00 (0 %)
SPY $ 670.85 $ 0.00 (0 %)
TLT $ 89.47 $ 0.00 (0 %)
GLD $ 368.50 $ 0.00 (0 %)
$ 24.33
$ 25.19
$ 24.27 x 3
$ 24.33 x 100
-- - --
$ 23.15 - $ 56.70
17,644,577
na
9.51B
$ 1.12
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-06-2025 09-30-2025 10-Q
2 08-01-2025 06-30-2025 10-Q
3 05-01-2025 03-31-2025 10-Q
4 02-21-2025 12-31-2024 10-K
5 11-07-2024 09-30-2024 10-Q
6 08-01-2024 06-30-2024 10-Q
7 05-02-2024 03-31-2024 10-Q
8 02-23-2024 12-31-2023 10-K
9 11-03-2023 09-30-2023 10-Q
10 08-03-2023 06-30-2023 10-Q
11 05-04-2023 03-31-2023 10-Q
12 02-24-2023 12-31-2022 10-K
13 11-03-2022 09-30-2022 10-Q
14 08-03-2022 06-30-2022 10-Q
15 05-04-2022 03-31-2022 10-Q
16 02-25-2022 12-31-2021 10-K
17 11-04-2021 09-30-2021 10-Q
18 08-05-2021 06-30-2021 10-Q
19 05-06-2021 03-31-2021 10-Q
20 02-26-2021 12-31-2020 10-K
21 10-30-2020 09-30-2020 10-Q
22 08-06-2020 06-30-2020 10-Q
23 05-07-2020 03-31-2020 10-Q
24 02-27-2020 12-31-2019 10-K
25 11-06-2019 09-30-2019 10-Q
26 08-08-2019 06-30-2019 10-Q
27 05-09-2019 03-31-2019 10-Q
28 03-13-2019 12-31-2018 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

ai-stocks-slide-again-bitcoin-dips-near-100000-whats-moving-markets-thursday
AI Stocks Slide Again, Bitcoin Dips Near $...
11/06/2025 17:45:11

After a brief and cautious rebound on Wednesday, risk-off sentiment returned sharply on Thursday, with AI-linked stocks leading...

mrna-vaccine-maker-moderna-lowers-rd-spending-tightens-sales-forecast
mRNA Vaccine Maker Moderna Lowers R&D Spen...
11/06/2025 17:29:25

Moderna posts a smaller Q3 loss, trims 2025 sales forecast, cuts R&D costs, and boosts cash outlook as COVID vaccine demand...

moderna-q3-2025-earnings-call-transcript
Moderna Q3 2025 Earnings Call Transcript
11/06/2025 17:08:17

Moderna reported third-quarter financial results on Thursday. The transcript from the company's earnings call has been prov...

moderna-narrows-fy2025-sales-guidance-from-1500b-2200b-to-1600b-2000b-vs-1899b-est
Moderna Narrows FY2025 Sales Guidance from...
11/06/2025 12:02:42

Moderna (NASDAQ:MRNA) narrows FY2025 sales outlook from $1.500 billion-$2.200 billion to $1.600 billion-$2.000 billion vs $1.89...

moderna-q3-eps-051-beats-202-estimate-sales-1016b-beat-886539m-estimate
Moderna Q3 EPS $(0.51) Beats $(2.02) Estim...
11/06/2025 12:02:07

Moderna (NASDAQ:MRNA) reported quarterly losses of $(0.51) per share which beat the analyst consensus estimate of $(2.02) by 74...

earnings-scheduled-for-november-6-2025
Earnings Scheduled For November 6, 2025
11/06/2025 11:12:19

Core News & Articles
10 Health Care Stocks Whale Activity In To...
11/05/2025 17:35:20

moderna-stock-is-sliding-monday-whats-going-on
Moderna Stock Is Sliding Monday: What's Go...
11/03/2025 20:54:35

Moderna stock is trading sharply lower Monday afternoon as recent clinical setbacks overshadowed positive pipeline news.

Core News & Articles
10 Health Care Stocks Whale Activity In To...
11/03/2025 17:35:20

top-stocks-with-earnings-this-week-joby-ionq-amd-and-more
Top Stocks With Earnings This Week: Joby, ...
11/03/2025 14:14:07

Retail investors are preparing for another busy week of earnings season with more than 1,600 companies set to report through Fr...

moderna-has-dosed-the-first-patient-in-a-phase-12-study-of-mrna-2808-the-companys-investigational-mrna-based-t-cell-engager-for-relapsed-or-refractory-multiple-myeloma
Moderna Has Dosed The First Patient In A P...
11/03/2025 12:08:37

moderna-mrna-stock-is-trading-lower-friday-whats-going-on
Moderna (MRNA) Stock Is Trading Lower Frid...
10/31/2025 19:57:43

Moderna shares are trading lower Friday afternoon, giving back a portion of gains seen Thursday.

Core News & Articles
10 Health Care Stocks Whale Activity In To...
10/30/2025 17:35:24

is-moderna-inc-gaining-or-losing-market-support
Is Moderna Inc Gaining or Losing Market Su...
10/30/2025 16:00:50

watching-moderna-shares-spike-higher-traders-circulate-unconfirmed-rumor-company-has-been-in-talks-to-be-acquired-with-at-least-one-large-drugmaker-on-a-deal-of-significant-scope-a-person-familiar-with-the-discussions-told-stat
Watching Moderna; Shares Spike Higher, Tra...
10/30/2025 15:14:37

https://www.statnews.com/2025/10/30/moderna-rise-fall-biotech-analysis-from-pandemic-rise-to-mrna-crash

Core News & Articles
'US Fires Top Health Official Who Opposed ...
10/28/2025 12:50:58

https://www.bloomberg.com/news/articles/2025-10-28/us-fires-top-health-official-who-opposed-widely-used-covid-shots?srnd=homepa...

ubs-maintains-buy-on-moderna-lowers-price-target-to-40
UBS Maintains Buy on Moderna, Lowers Price...
10/23/2025 21:02:15

UBS analyst Eliana Merle maintains Moderna (NASDAQ:MRNA) with a Buy and lowers the price target from $70 to $40.

jp-morgan-maintains-underweight-on-moderna-lowers-price-target-to-25
JP Morgan Maintains Underweight on Moderna...
10/23/2025 16:18:24

JP Morgan analyst Jessica Fye maintains Moderna (NASDAQ:MRNA) with a Underweight and lowers the price target from $26 to $25.

moderna-stops-cmv-program-as-vaccine-falls-short-in-preventing-infection
Moderna Stops CMV Program As Vaccine Falls...
10/23/2025 14:26:15

Moderna ends its CMV vaccine program after a Phase 3 trial failed to meet efficacy goals, but maintains its 2028 breakeven and ...

citigroup-maintains-neutral-on-moderna-lowers-price-target-to-28
Citigroup Maintains Neutral on Moderna, Lo...
10/23/2025 10:59:18

Citigroup analyst Geoff Meacham maintains Moderna (NASDAQ:MRNA) with a Neutral and lowers the price target from $30 to $28.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION